CT1812
|
C650901-5mg
|
≥97% |
1802632-22-9 |
5mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
CT1812
|
C650901-50mg
|
≥97% |
1802632-22-9 |
50mg
|
¥ 25500.9
|
期货,请咨询 |
阿拉丁 |
CT1812
|
C650901-10mg
|
≥97% |
1802632-22-9 |
10mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
Cycloartenol
|
C650900-5mg
|
≥98% |
469-38-5 |
5mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
Cycloartenol
|
C650900-1mg
|
≥98% |
469-38-5 |
1mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
CJJ300
|
C650892-5mg
|
≥95% |
1807631-83-9 |
5mg
|
¥ 1300.9
|
期货,请咨询 |
阿拉丁 |
CJJ300
|
C650892-50mg
|
≥95% |
1807631-83-9 |
50mg
|
¥ 7000.9
|
期货,请咨询 |
阿拉丁 |
CJJ300
|
C650892-25mg
|
≥95% |
1807631-83-9 |
25mg
|
¥ 4400.9
|
期货,请咨询 |
阿拉丁 |
CJJ300
|
C650892-10mg
|
≥95% |
1807631-83-9 |
10mg
|
¥ 2100.9
|
期货,请咨询 |
阿拉丁 |
CJJ300
|
C650892-100mg
|
≥95% |
1807631-83-9 |
100mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
Chitinase-IN-2 hydrochloride
|
C650885-5mg
|
≥99% |
2070014-83-2 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
Chitinase-IN-2 hydrochloride
|
C650885-50mg
|
≥99% |
2070014-83-2 |
50mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
Chitinase-IN-2 hydrochloride
|
C650885-2mg
|
≥99% |
2070014-83-2 |
2mg
|
¥ 2333.9
|
期货,请咨询 |
阿拉丁 |
Chitinase-IN-2 hydrochloride
|
C650885-10mg
|
≥99% |
2070014-83-2 |
10mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
Chitinase-IN-2 hydrochloride
|
C650885-100mg
|
≥99% |
2070014-83-2 |
100mg
|
¥ 21000.9
|
期货,请咨询 |
阿拉丁 |
CCR7 Ligand 1
|
C650864-5mg
|
≥99% |
681514-83-0 |
5mg
|
¥ 5950.9
|
期货,请咨询 |
阿拉丁 |
CCR7 Ligand 1
|
C650864-50mg
|
≥99% |
681514-83-0 |
50mg
|
¥ 29500.9
|
期货,请咨询 |
阿拉丁 |
CCR7 Ligand 1
|
C650864-10mg
|
≥99% |
681514-83-0 |
10mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
C188
|
C650844-5mg
|
|
823828-18-8 |
5mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
CB2R/FAAH modulator-2
|
C650828-5mg
|
|
2876918-68-0 |
5mg
|
¥ 900.9
|
期货,请咨询 |
阿拉丁 |
CB2R/FAAH modulator-2
|
C650828-10mg
|
|
2876918-68-0 |
10mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
CpG ODN 10101
|
C650825-5mg
|
≥94% |
1234402-77-7 |
5mg
|
¥ 12500.9
|
期货,请咨询 |
阿拉丁 |
CpG ODN 10101
|
C650825-1mg
|
≥94% |
1234402-77-7 |
1mg
|
¥ 6200.9
|
期货,请咨询 |
阿拉丁 |
CpG ODN 10101
|
C650825-10mg
|
≥94% |
1234402-77-7 |
10mg
|
¥ 19800.9
|
期货,请咨询 |
阿拉丁 |